Sri Rao is a senior healthcare and MedTech executive with more than 25 years of experience driving commercial strategy, market development, and therapy development across startups and global organizations. He is known for building high-performing teams, launching innovative therapies, and bridging clinical and commercial strategies to accelerate adoption and sustainable growth.
Most recently, Sri served as Senior U.S. Director of Therapy Development at Ancora Heart, where he built and led a national organization, expanded enrollment across more than 90 clinical trial sites, and shaped clinical and field strategy for a novel FDA-trial heart failure therapy.
